BioSpace News Archive

Drug Development

Celgene and bluebird bio Rushing to Stay Ahead of the CAR-T Pack

Celgene Corporation and bluebird bio published interim data from CRB-401, their Phase I trial of bb2121, their CAR-T therapy in patients with relapsed and refractory multiple myeloma.

May 2, 2019
·
3 min read
·
Mark Terry
Business

Healthcare and Biopharma Execs Debate the Advantages of Artificial Intelligence

There has been a string of news stories about how big pharma is teaming up with various artificial intelligence (AI) companies to leverage real-world data and speed drug development.

May 2, 2019
·
4 min read
·
Mark Terry
Business

How Much Did These Pharma CEOs Earn in 2017?

For those select few who achieve the role of chief executive officer of a multi-national corporation, the compensation packages are typically quite large – especially when compared to the average salaries of company employees.

May 2, 2019
·
2 min read
·
Alex Keown
Policy

Aging Drugs Apply Pressure on Biopharma

Biopharma has several unique challenges, but one of them is the patent cliff. In an industry where only about one in 10 compounds actually makes it to market on average, those drugs aren’t able to stay on the market very long before their patents end and generic competition begins.

May 2, 2019
·
4 min read
·
Mark Terry
Drug Development

Research Roundup: Lab-on-a-Chip, Alzheimer’s Advances, Breast Cancer and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

May 2, 2019
·
6 min read
·
Mark Terry
Job Trends

Two Pharma Companies Expand on the Coasts, Open New Facilities

Takeda’s new 165.000 square foot site is home to more than 250 employees focused on leveraging specialized drug discovery technologies and advancing discovery research in gastroenterology and neuroscience,

May 2, 2019
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: May 3

Biopharma companies make changes to their C-suite leadership teams, with hires at uBiome, Enzyre, Sobi, Amylyx, Mission Therapeutics, and more.

May 2, 2019
·
5 min read
·
Alex Keown
Medigene AG: Medigene presented data on favorable safety pattern of PRAME-specific TCR on neuronal cells at 2019 ASGCT Meeting

Functional 2D and 3D in vitro assays using neuronal cells derived from iPSCs to assess the potential risk of TCR-mediated neurotoxicity

May 2, 2019
·
4 min read
Newly discovered gene mutation reduces fear and anxiety, and increases social interaction

Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction.

May 2, 2019
·
3 min read
Biotech Bay

TLC Earns Highest Ranks in Corporate Governance Evaluation for 5th Consecutive Year

TLC announced that it has for the fifth consecutive year been ranked in the top 5% of companies for Corporate Governance Evaluation by the Taiwan Stock Exchange Corporation and Taipei Exchange.

May 2, 2019
·
3 min read